Clinical trial
To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated…
NCT00398151 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00398151 |
|---|---|
| Title | To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366) |
| Official title | An Open-Label Study to Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | MK0476, montelukast sodium / Duration of Treatment: 12 Weeks |
| Enrollment | 58 |
| Start date | Aug 1, 2005 |
| Primary completion | Jan 18, 2006 |
| Completion | Jan 18, 2006 |
| First posted | Nov 10, 2006 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: